Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

M435-1279 is an inhibitor of ubiquitin-conjugating enzyme E2T (UBE2T).1 It binds to UBE2T (Kd = 50.5 µM), inhibits UBE2T-mediated degradation of receptor for activated C kinase 1 (RACK1), and reduces hyperactive Wnt/β-catenin signaling. M435-1279 reduces the viability of MKN45 and AGS gastric cancer cells when used at concentrations ranging from 4 to 32 µM. Intratumoral administration of M435-1279 (5 mg/kg per day) reduces tumor growth in an MKN45 mouse xenograft model.
WARNING This product is not for human or veterinary use.
1. A novel UBE2T inhibitor suppresses Wnt/β-